(Q35905013)

11 August 2017

1 reference

title

Antivascular cancer treatments: imaging biomarkers in pharmaceutical drug development (English)

1 reference

11 August 2017

0 references

Galbraith SM

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

British Journal of Radiology

11 August 2017

published in

1 reference

11 August 2017

volume

76 Spec No 1

1 reference

11 August 2017

page(s)

S83-6

1 reference

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

Development of matrix metalloproteinase inhibitors in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer a

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

In vivo molecular target assessment of matrix metalloproteinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first-pass leakage profile model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

Magnetic resonance imaging applications in the evaluation of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation: validation by intravital microscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

Identification of angiogenesis in primary breast carcinoma according to the image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F15255885

21 January 2018

Identifiers

DOI

10.1259/BJR/15255885

1 reference

11 August 2017

1 reference